M. Petryk et al. / Tetrahedron: Asymmetry xxx (2017) xxx–xxx
9
4.4.4. (S)-N-(1-Cyclohexylethyl)-30,50-diformyl-40-hydroxy-[1,10-
biphenyl]-4-carboxamide 2d
4.5.2. 4,40,400-((2E,5E,11E,14E,17E)-12,72,132-Trihydroxy-
3,5,9,11,15,17-hexaaza-1,7,13(1,3)-tribenzena-4,10,16(1,2)-
tricyclohexanacyclooctadecaphane-2,5,8,11,14,17-hexaene-
15,75,135-triyl)tris(N-((S)-1-phenylethyl)benzamide)–
Calixsalen 4b
According to C: 4-bromo-2,6-diformylphenol (458 mg, 2 mmol),
6d (550 mg, 2 mmol), K2CO3 (828 mg, 6 mmol) and [Pd(PPh3)4]
(50 mg, 0.04 mmol) were stirred in degassed toluene (10 mL)
under an argon atmosphere for 15 min at room temperature. Next,
a 1:1 mixture of degassed EtOH/H2O (10 mL) was added and mix-
ture was stirred for 16 h at 80 °C. After workup and purification, 2d
was obtained as a light yellow solid (130 mg, 17%); mp 205–
207 °C; HRMS (ESI) calcd for C23H25NO4 [MꢁH]ꢁ 378.1711; found
378.1690; 1H NMR (300 MHz, DMSO) d 11.67 (s, 1H, AOH), 10.33
(s, 2H, ACHO), 8.40 (s, 2H, Ar0), 8.20 (d, J = 8.5 Hz, 1H, ANH), 7.98
(d, J = 8.2 Hz, 2H, Ar), 7.82 (d, J = 8.2 Hz, 2H, Ar), 3.97–3.77 (m,
1H, ACH), 1.83–1.53 (m, 5H, Cy), 1.53–1.35 (m, 1H, Cy), 1.27–
1.06 (m, 3H, Cy), 1.13 (d, J = 6.7 Hz, 2H, ACH3), 1.05–0.85 (m, 1H,
Cy); 13C NMR (75 MHz, DMSO) d 192.79 (ACHO), 165.49 (ACO),
162.18 (ACOH), 140.27 (Ar), 135.52 (Ar), 134.51 (Ar), 131.46 (Ar),
128.62 (Ar), 126.38 (Ar), 124.42 (Ar), 49.76 (ACH), 42.88 (Cy),
29.78 (Cy), 29.47 (Cy), 26.49 (Cy), 26.23 (Cy), 18.17 (ACH3); FTIR
(ATR): ṽ = 3327, 2975, 2928, 2850, 1686, 1662, 1632, 1610, 1534,
According to B: To trans-(1R,2R)-diaminocyclohexane (23 mg,
0.2 mmol) dissolved in 20 mL of methylene chloride dialdehyde
3b (75 mg, 0.2 mmol) was added in one portion. The resulting mix-
ture was stirred at room temperature for 24 h. The solvent was
evaporated under vacuum and the yellow solid product was
obtained. The [3+3] and [4+4] products were obtained with yields
80% an 20% respectively. HRMS (ESI) calcd for [3+3] C87H87N9O6 [M
+H]+ 1354.6852; found 1354.6842, for [4+4] C116H116N12O8 [M+H]+
1806.9145; found 1806.9176; mp >300 °C (dec.); 1H NMR
(300 MHz, CDCl3, asterisk indicate signals originated from [4+4]
macrocycle) d 14.36 (s, 1H, AOH), 13.86⁄, 8.68 (s, 1H, AN@CHA),
8.62⁄, 8.41⁄, 8.28 (s, 1H, AN@CHA), 8.12⁄, 8.02 (s, 1H, Ar), 7.95⁄,
7.84⁄, 7.72 (d, J = 7.9 Hz, 2H, Ar), 7.66⁄, 7.44–7.42 (m, 2H, Ar),
7.38–7.34 (m, 3H, Ar), 7.34–7.30 (m, 2H, Ar), 7.27–7.25 (m, 1H,
Ar), 7.10⁄, 6.92 (d, J = 7.3 Hz, 1H, ANH), 5.39–5.33 (m, 1H, ACH),
3.51–3.45 (m, 1H, ACHN@), 3.42–3.38⁄, 3.36–3.30 (m, 1H,
ACHN@), 3.24–3.18⁄, 2.00–1.70 (m, 6H, Cy), 1.67 (d, J = 6.8 Hz,
2H, ACH3), 1.53–1.48 (m, 2H, Cy).13C NMR (151 MHz, CDCl3) d
166.54 (AC@O), 164.00 (AN@CHA), 162.50 (AN@CHA), 156.43
(CAOH), 143.48 (Ar), 142.84 (Ar), 132.69 (s), 132.07 (Ar), 129.32
(Ar), 128.69 (Ar), 127.63 (Ar), 127.31 (Ar), 126.28 (Ar), 126.22
(Ar), 124.32 (Ar), 118.85 (Ar), 75.03 (ACHN@), 72.96 (ACHN@),
49.31 (ACH), 33.04 (Cy), 32.80 (Cy), 24.39 (Cy), 24.29 (Cy), 21.90
(ACH3) ppm; FTIR (ATR): ṽ = 3301, 3029, 2929, 2857, 1632, 1607,
1534, 1494, 1450, 1376, 1263, 1208, 1143, 1095, 1008, 850,
1446, 1383, 1320, 1285, 1272, 1237, 980, 848, 676 cmꢁ1; [
a] =
D
+38.5 (c 1, methanol).
4.5. General procedure for the synthesis of calixsalens 3a–3d (D)
To trans-(1R,2R)-diaminocyclohexane (R,R)-1 (1 equiv) dis-
solved in dry dichloromethane, dialdehyde 2 (1 equiv) was added
in one portion. The resulting mixture was stirred at room temper-
ature for 24 h in argon atmosphere. The solvent was evaporated
under vacuum and the yellow solid product was obtained.
737 cmꢁ1
.
4.5.3. 4,40,400-((2E,5E,11E,14E,17E)-12,72,132-Trihydroxy-
3,5,9,11,15,17-hexaaza-1,7,13(1,3)-tribenzena-4,10,16(1,2)-
tricyclohexanacyclooctadecaphane-2,5,8,11,14,17-hexaene-
15,75,135-triyl)tris(N-((R)-1-cyclohexylethyl)benzamide)–
Calixsalen 4c
A: According to B: To trans-(1R,2R)-diaminocyclohexane
(23 mg, 0.2 mmol) dissolved in 20 mL of methylene chloride
dialdehyde 3c (76.5 mg, 0.2 mmol) was added in one portion. The
resulting mixture was stirred at room temperature for 24 h. The
solvent was evaporated under vacuum and the yellow solid pro-
duct was obtained. [3+3] and [4+4] products were obtained with
yields 80% and 20% respectively. HRMS (ESI) calcd for [3+3]
4.5.1. 4,40,400-((2E,5E,11E,14E,17E)-12,72,132-Trihydroxy-
3,5,9,11,15,17-hexaaza-1,7,13(1,3)-tribenzena-4,10,16(1,2)-
tricyclohexanacyclooctadecaphane-2,5,8,11,14,17-hexaene-
15,75,135-triyl)tris(N-((R)-1-phenylethyl)benzamide)–
Calixsalen 4a
According to D: To trans-(1R,2R)-diaminocyclohexane (23 mg,
0.2 mmol) dissolved in 20 mL of methylene chloride, dialdehyde
3a (75 mg, 0.2 mmol) was added in one portion. The resulting mix-
ture was stirred at room temperature for 24 h. The solvent was
evaporated under vacuum and the yellow solid product was
obtained. [3+3] and [4+4] products were obtained with yield 83%
and 17% respectively. The [3+3] product 3a was purified by
repeated crystallization from dichloromethane/acetonitrile solu-
tion. HRMS (ESI) calcd for C87H87N9O6 [M+H]+1354.6852; found
1354.6841; mp >300 °C (dec.); 1H NMR (300 MHz, CDCl3) d 14.37
(s, 1H, AOH), 8.71 (s, 1H, AN@CHA), 8.28 (s, 1H, AN@CHA), 8.04
(s, 1H, Ar), 7.74 (d, J = 8.1 Hz, 2H, Ar), 7.41–7.33 (m, 6H, Ar,),
7.29–7.26 (m, 2H, Ar), 6.75 (d, J = 7.7 Hz, 1H, ANH), 5.35 (p,
J = 6.9 Hz, 1H, ACH), 3.52–3.42 (m, 1H, ACHN@), 3.41–3.29 (m,
1H, ACHN@), 1.98–1.71 (m, 6H, Cy), 1.65 (d, J = 6.9 Hz, 3H,
ACH3), 1.54–1.48 (m, 2H, Cy). 13C NMR (101 MHz, CDCl3) 13C
NMR (151 MHz, CDCl3) d 166.45 (AC@O), 163.80 (AN@CHA),
162.37 (AN@CHA), 156.15 (ACAOH), 143.35 (Ar), 143.03 (Ar),
132.68 (Ar), 132.15 (Ar), 129.46 (Ar), 128.71 (Ar), 128.22 (Ar),
127.54 (Ar), 127.36 (Ar), 126.40 (Ar), 126.28 (Ar), 124.32 (Ar),
118.98 (Ar), 75.16 (ACHN@), 73.03 (ACHN@), 49.37 (ACHA),
33.10 (Cy), 33.03 (Cy), 24.39 (Cy), 24.30 (Cy), 21.87 (ACH3) ppm;
FTIR (ATR): ṽ = 3312, 3029, 2930, 2858, 1633, 1607, 1533, 1501,
1448, 1375, 1344, 1290, 1263, 1206, 1143, 1097, 1006, 850,
C
C
87H105N9O6 [M+H]+ 1372.8261; found 1372.8290, for [4+4]
116H140N12O8 [M+H]+ 1831.1023; found 1831.1039; mp >300 °C
(dec.);1H NMR (300 MHz, CDCl3, asterisk indicate signals origi-
nated from [4+4] macrocycle) d 14.40 (s, 1H, AOH), 13.89⁄, 8.74
(s, 1H, AN@CHA), 8.64⁄, 8.32 (s, 1H, AN@CHA), 8.10 (s, 1H, Ar),
7.97⁄, 7.74 (d, J = 8.0 Hz, 2H, Ar), 7.67⁄, 7.43 (d, J = 7.9 Hz, 2H, Ar),
7.34 (s, 1H, Ar), 7.15⁄, 6.68⁄, 6.21 (d, J = 8.8 Hz, 1H, ANH), 4.19⁄,
4.09 (dq, J = 13.6, 6.7 Hz, 1H, ACH), 3.55–3.46 (m, 1H, ACHN@),
3.43–3.36 (m, 1H, ACHN@), 3.26⁄, 1.96–1.65 (m, 10H, Cy), 1.53–
1.45 (m, 2H, Cy), 1.23 (d, J = 6.7 Hz, 2H, ACH3), 1.32–1.00 (m, 6H,
Cy).13
C NMR (151 MHz, CDCl3) d 166.59 (AC@O), 163.74
(AN@CHA), 162.29 (AN@CHA), 156.08 (CAOH), 142.82 (Ar),
133.24 (Ar), 129.58 (Ar), 127.81 (Ar), 127.37 (Ar), 126.47 (Ar),
126.23 (Ar), 124.19 (Ar), 119.06 (Ar), 75.19 (ACHN@), 72.93
(ACHN@), 49.99 (ACH), 43.24 (Cy), 33.20 (Cy), 33.13 (Cy), 29.32
(Cy), 29.18 (Cy), 26.43 (Cy), 26.21 (Cy), 24.37 (Cy), 24.29 (Cy),
17.99 (ACH3) ppm; FTIR (ATR): ṽ = 3311, 3049, 2925, 2852, 1631,
1607, 1534, 1501, 1449, 1375, 1344, 1290, 1264, 1207, 1143,
735 cmꢁ1; [
a]
D = ꢁ306.1 (c 1, chloroform).
1097, 850, 735 cmꢁ1
.